Article
Mitochondrial therapies for Parkinson's disease
1 Jan 2010
Abstract excerpt
Parkinson's disease (PD) is marked by widespread neurodegeneration in the brain in addition to a selective yet prominent and progressive loss of nigrostriatal dopaminergic neurons. Of the multiple theories suggested in the pathogenesis of PD, mitochondrial dysfunction takes a center stage in both sporadic and familial forms of illness. Deficits in mitochondrial functions due to impaired bioenergetics, aging...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
